Forrester Research, Inc. (FORR) Balance Sheet

The trajectory here is one of consistent erosion, not stabilization: total assets have declined in eight of the last ten quarters, and equity has fallen every quarter since 2024Q3 with only a brief 2026Q1 dip. Critically, this is not the profile of a company rebuilding its balance sheet through cash generation; retained earnings fell $125M over the same window, which more than accounts for the equity decline and implies the underlying business is consuming book value rather than compounding it. The modest $19.6M in debt reduction over the period is immaterial against this scale of contraction, suggesting the balance sheet is shrinking because the business is shrinking.

The goodwill roll-off is the dominant force on the asset side, wiping out roughly $134M of stated value and, if the trend persists at the pace seen between 2024Q4 and 2025Q3 (a ~$83M single-period drop), may not yet be fully resolved. That the company took these charges while revenue contracted ten straight quarters suggests the acquired growth assumptions have been formally abandoned by management, but investors should note that goodwill is only a proxy—harder to verify are any remaining intangibles and the $60.9M PPE balance, which has risen 37% from 2025Q1 lows even as revenue declines, a divergence that warrants investigation into whether capital spending is being capitalized into assets that will generate future returns. The remaining $109M goodwill still represents over a quarter of assets, leaving residual impairment risk if the consulting segment continues to underperform.

The equity contraction is nearly fully explained by the $125M drawdown in retained earnings, indicating operating shortfalls and impairments—rather than buybacks or dividends—are absorbing the book value, consistent with the cash flow finding that SBC of $32.2M over ten quarters roughly equals cumulative free cash flow. With $46M of retained earnings remaining against a $121.6M equity base, the buffer for absorbing further charges is thin; another quarter of the magnitude seen in 2025Q3 (where retained earnings dropped ~$34M) would cut the cushion in half. This suggests any additional impairment or operating loss would flow straight through to a materially weaker equity position, potentially pressuring covenants or counterparty confidence if the trend continues unchecked.

A current ratio that has printed below 1.0 in six of ten quarters signals a working capital structure that relies on steady cash conversion; with only $59.5M of cash and $64.0M of debt, net debt of $4.5M looks modest, but that apparent comfort is undercut by the cash flow finding that quarterly free cash flow swung from $19.4M in 2026Q1 to $2.3M in 2026Q2. The stability of the debt balance in the $62-84M range suggests management has kept leverage flat rather than drawn down facilities, which may indicate covenant constraints or a preference for flexibility, but it also means the company has not built a larger cash war chest during the downturn. For a firm whose deferred revenue is shrinking, the liquidity position appears adequate only if operating cash flow remains positive—a condition the cash flow analysis suggests is not reliably met.

Deferred revenue is the most informative forward indicator for a subscription-led research business, and its slide from $193.7M to $147.3M has been almost monotonic with only minor quarterly upticks, mirroring rather than diverging from the reported revenue decline. The 2026Q1 spike to $173.2M followed by a $26M drop to $147.3M in Q2 suggests that any booking strength has been transient rather than a turn in renewal behavior, reinforcing the prior income statement finding of no visible stabilization. If deferred revenue is a leading indicator of billings, the current $147.3M balance against a $100.2M quarterly revenue run-rate implies roughly 1.47 quarters of contracted visibility, which is thin for a business model predicated on annual and multi-year subscriptions.